Panbela Therapeutics Inc

NASDAQ:PBLA  
2.00
+0.09 (+4.71%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Panbela Therapeutics Inc Stock, NASDAQ:PBLA

712 Vista Boulevard, Suite 305, Waconia, Minnesota 55387
United States of America
Phone: +1.952.479.1196
Number of Employees: 6

Description

Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The firmâ??s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance in multiple tumor types. The company was founded by Michael T. Cullen, Jr. and Thomas X. Neenan on September 21, 2011 and is headquartered in Waconia, MN.